Autophagy in nonalcoholic steatohepatitis

Expert Review of Gastroenterology and Hepatology

Volumn 5, Issue 2, 2011, Pages 159-166

  Amir, Muhammad ^a   Czaja, Mark J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

chaperone mediated autophagy; insulin sensitivity; liver injury; macroautophagy; nonalcoholic fatty liver disease; oxidative stress

Indexed keywords

AUTOPHAGY PROTEIN 5; CARBAMAZEPINE; CHOLESTEROL; FAT DROPLET; FATTY ACID; PROTEIN P62; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL;

AGING; ALPHA 1 ANTITRYPSIN DEFICIENCY; AUTOPHAGY; CELL DEATH; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; FIBROGENESIS; HUMAN; HYPERINSULINEMIA; IMMUNOMODULATION; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER TOXICITY; LYSOSOME; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; CELL DEATH; FATTY LIVER; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIVER CIRRHOSIS; LIVER NEOPLASMS;

EID: 79954475565     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.11.4     Document Type: Review

References (68)

1. Mehrpour M, Esclatine A, Beau I, Codogno P. Autophagy in health and disease. 1. Regulation and signifcance of autophagy: an overview. Am. J. Physiol. Cell Physiol. 298(4), C776-C785 (2010).
2. Orenstein SJ, Cuervo AM. Chaperone-mediated autophagy: molecular mechanisms and physiological relevance. Semin. Cell Dev. Biol. 21(7), 719-726 (2010).
3. Komatsu M, Waguri S, Chiba T et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441(7095), 880-884 (2006).
4. Finn PF, Dice JF. Proteolytic and lipolytic responses to starvation. Nutrition 22(7-8), 830-844 (2006).
5. Iwata J, Ezaki J, Komatsu M et al. Excess peroxisomes are degraded by autophagic machinery in mammals. J. Biol. Chem. 281(7), 4035-4041 (2006). (Pubitemid 43847828)
6. Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy Arch. Biochem. Biophys. 462(2), 245-253 (2007). (Pubitemid 46876640)
7. Cheung O, Sanyal AJ. Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. Semin. Liver Dis. 28(4), 351-359 (2008).
8. Cusi K. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin. Liver Dis. 13(4), 545-563 (2009).
9. Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology 114(4), 842-845 (1998). (Pubitemid 28160420)
10. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury J. Clin. Invest. 114(2), 147-152 (2004). (Pubitemid 39071617)
11. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH. The role of cytokines and chemokines in the development of steatohepatitis. Semin. Liver Dis. 27(2), 173-193 (2007). (Pubitemid 46871663)
12. Czaja MJ. Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications. Am. J. Physiol. Cell Physiol. 298(5), C973-C978 (2010).
13. Singh R, Kaushik S, Wang Y et al. Autophagy regulates lipid metabolism. Nature 458 (7242), 1131-1135 (2009).
14. Ding WX, Li M, Chen X et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology 139(5), 1740-1752 (2010).
15. Pan M, Maitin V, Parathath S et al. Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control. Proc. Natl Acad. Sci. USA 105(15), 5862-5867 (2008). (Pubitemid 351758463)
16. Cuervo AM, Bergamini E, Brunk UT et al. Autophagy and aging: the importance of maintaining 'clean' cells. Autophagy 1(3), 131-140 (2005).
17. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: fndings from the third National Health and Nutrition Examination Survey. JAMA 287(3), 356-359 (2002). (Pubitemid 34251969)
18. Koga H, Kaushik S, Cuervo AM. Altered lipid content inhibits autophagic vesicular fusion. FASEB J. 24(8), 3052-3065 (2010).
19. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J. Clin. Invest. 113(11), 1582-1588 (2004). (Pubitemid 39071681)
20. Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am. J. Physiol. Gastrointest. Liver Physiol. 293(1), G1-G4 (2007). (Pubitemid 47105157)
21. Wahren J, Sato Y, Ostman J, Hagenfeldt L, Felig P. Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise. J. Clin. Invest. 73(5), 1367-1376 (1984).
22. Nagle CA, Klett EL, Coleman RA. Hepatic triacylglycerol accumulation and insulin resistance. J. Lipid Res. 50(Suppl.), S74-S79 (2009).
23. Larter CZ, Yeh MM, Haigh WG et al. Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways. J. Hepatol. 48(4), 638-647 (2008).
24. Lam TK, Carpentier A, Lewis GF et al. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am. J. Physiol. Endocrinol. Metab. 284(5), E863-E873 (2003). (Pubitemid 36444021)
25. Yang L, Li P, Fu S, Calay ES, Hotamisligil GS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11(6), 467-478 (2010).
26. Liu HY, Han J, Cao SY et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FOXO1-dependent expression of key autophagy genes by insulin. J. Biol. Chem. 284(45), 31484-31492 (2009).
27. Sengupta A, Molkentin JD, Yutzey KE. FOXO transcription factors promote autophagy in cardiomyocytes. J. Biol. Chem. 284(41), 28319-28331 (2009).
28. Zhao Y, Yang J, Liao W et al. Cytosolic FOXO1 is essential for the induction of autophagy and tumour suppressor activity Nat Cell Biol. 12(7), 665-675 (2010).
29. Valenti L, Rametta R, Dongiovanni P et al. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57(5), 1355-1362 (2008).
30. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99(8), 1497-1502 (2004). (Pubitemid 39193189)
31. Gozuacik D, Kimchi A. Autophagy and cell death. Curr. Top. Dev. Biol. 78, 217-245 (2007).
32. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev. Mol. Cell Biol. 8(9), 741-752 (2007). (Pubitemid 47312826)
33. Hara T, Nakamura K, Matsui M et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441(7095), 885-889 (2006).
34. Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J. Exp. Med. 204(1), 25-31 (2007). (Pubitemid 46148752)
35. Wang Y, Singh R, Xiang Y, Czaja MJ. Macroautophagy and chaperone-mediated autophagy are required for hepatocyte resistance to oxidant stress. Hepatology 52(1), 266-277 (2010).
36. Farre JC, Manjithaya R, Mathewson RD, Subramani S. PpAtg30 tags peroxisomes for turnover by selective autophagy. Dev. Cell 14(3), 365-376 (2008).
37. Yousef S, Perozzo R, Schmid I et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol. 8(10), 1124-1132 (2006). (Pubitemid 44473608)
38. Pattingre S, Tassa A, Qu X et al. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell 122(6), 927-939 (2005). (Pubitemid 41345209)
39. Rodriguez-Enriquez S, Kai Y, Maldonado E, Currin RT, Lemasters JJ. Roles of mitophagy and the mitochondrial permeability transition in remodeling of cultured rat hepatocytes. Autophagy 5(8), 1099-1106 (2009).
40. Dawson TL, Gores GJ, Nieminen AL, Herman B, Lemasters JJ. Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes. Am. J. Physiol. 264(4 Pt 1), C961-C967 (1993). (Pubitemid 23118118)
41. Caldwell SH, Swerdlow RH, Khan EM et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. J. Hepatol. 31(3), 430-434 (1999). (Pubitemid 29408724)
42. Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 8(1), 3-5 (2005).
43. Singh R, Wang Y, Xiang Y et al. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology 49(1), 87-96 (2009).
44. Zhang C, Cuervo AM. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med. 14(9), 959-965 (2008).
45. Lin HZ, Yang SQ, Chuckaree C et al. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat. Med. 6(9), 998-1003 (2000).
46. Feldstein AE, Canbay A, Guicciardi ME et al. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 39(6), 978-983 (2003). (Pubitemid 37523769)
47. Wang Y, Singh R, Massey AC et al. Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. J. Biol. Chem. 283(8), 4766-4777 (2008).
48. Tsiotra PC, Tsigos C. Stress, the endoplasmic reticulum, and insulin resistance. Ann. NY Acad. Sci. 1083, 63-76 (2006). (Pubitemid 44970398)
49. Ogata M, Hino S, Saito A et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell Biol. 26(24), 9220-9231 (2006). (Pubitemid 44904418)
50. Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology 48(2), 670-678 (2008).
51. Saitoh T, Akira S. Regulation of innate immune responses by autophagy-related proteins. J. Cell Biol. 189(6), 925-935 (2010).
52. Saitoh T, Fujita N, Jang MH et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1b production. Nature 456(7219), 264-268 (2008).
53. Rivera CA, Adegboyega P, van Rooijen N et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J. Hepatol. 47(4), 571-579 (2007). (Pubitemid 47331747)
54. Brun P, Castagliuolo I, Di Leo V et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292(2), G518-G525 (2007).
55. Xu Y, Jagannath C, Liu XD et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27(1), 135-144 (2007). (Pubitemid 47089027)
56. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 134(6), 1655-1669 (2008). (Pubitemid 351615417)
57. Singh R, Xiang Y, Wang Y et al. Autophagy regulates adipose mass and differentiation in mice. J. Clin. Invest. 119(11), 3329-3339 (2009).
58. Bugianesi E, Leone N, Vanni E et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123(1), 134-140 (2002). (Pubitemid 34747534)
59. Maiuri MC, Tasdemir E, Criollo A et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 16(1), 87-93 (2009).
60. White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin. Cancer Res. 15(17), 5308-5316 (2009).
61. Qu X, Yu J, Bhagat G et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112(12), 1809-1820 (2003). (Pubitemid 38063704)
62. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl Acad. Sci. USA 100(25), 15077-15082 (2003). (Pubitemid 37518019)
63. Ding ZB, Shi YH, Zhou J et al. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res. 68(22), 9167-9175 (2008).
64. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6(4), 304-312 (2007). (Pubitemid 46505881)
65. 1-antitrypsin Z and reduces hepatic fibrosis. Science 329(5988), 229-232 (2010).
66. Kalapos MP. Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events. Retrospective review of old data and call for new investigation. Adverse Drug React. Toxicol. Rev. 21(3), 123-141 (2002).
67. Yamaguchi K, Yang L, McCall S et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45(6), 1366-1374 (2007). (Pubitemid 46918320)
68. Imai Y, Varela GM, Jackson MB et al. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. Gastroenterology 132(5), 1947-1954 (2007). (Pubitemid 46677941)